EGA
PMD

Eagle Global Advisors’s Psychemedics Corporation PMD Stock Holding History

Eagle Global Advisors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,140
Closed -$328K – 375
2017
Q2 		$328K Hold
13,140
– – 0.01% 284
2017
Q1 		$263K Hold
13,140
– – 0.01% 310
2016
Q4 		$324K Hold
13,140
– – 0.01% 263
2016
Q3 		$260K Buy
+13,140
New +$244K 0.01% 285

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Eagle Global Advisors's PMD Position: Q3 2017 in Review

Eagle Global Advisors sold out of Psychemedics Corporation (PMD) in Q3 2017, closing a stake of 13,140 shares — an estimated $328K sold.

Eagle Global Advisors first reported a position in PMD in Q3 2016 and held it in 4 quarters. The position peaked at $328K in Q2 2017. 51 funds tracked by Wall St. Rank hold PMD as of Q3 2017.

  • Eagle Global Advisors reported no remaining Psychemedics Corporation position as of Q3 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 13,140 Psychemedics Corporation shares in Q3 2017, an estimated $328K.
  • Eagle Global Advisors first reported a position in Psychemedics Corporation in Q3 2016 and held it in 4 quarters.
  • Eagle Global Advisors's Psychemedics Corporation position peaked at $328K in Q2 2017.
  • 51 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.